… MDS Foundation as a collaborative international effort to refine its prognostic power. Our
purpose was to externally validate … retrospectively from our myelodysplastic syndrome (MDS) …

… This was a retrospective analysis of MDS cases, as defined by World Health Organization …
was to externally validate the new risk model calculated at time of initial MDS patients' referral …

… The diagnostic procedures were exactly the same as used in our retrospective study. All
blood and bone marrow smears were examined by the same investigator (CA and/or UG). The …

… A total of 152 patients with myelodysplastic syndrome (MDS) receiving a first stem cell …
The FCSS scores were retrospectively compared with patient outcomes in both univariate …

… The myelodysplastic syndromes (MDS) are a heterogeneous … Recent developments in the
treatment of MDS require refinement of … for the diagnosis and prognosis of MDS. Recently, we …

… events including cases of myelodysplastic syndrome and acute … the risk of myelodysplastic
syndrome and acute myeloid … inhibitor-related myelodysplastic syndrome and acute myeloid …

… the post-test probability of MDS [1]. In this study we validate this scoring system in a cohort
of … Thirty-two percent of all patients were diagnosed with MDS and 9% had suspected MDS. …

… in MDS have become increasingly common, but with limited data on efficacy. We therefore
performed a retrospective … in our cohort has not been validated in this setting and cannot give …

… retrospectively collected the clinical and haematological data of 190 patients diagnosed with
MDS … which was re-categorised as myelodysplastic syndrome/myeloproliferative syndrome (…

… We conducted a retrospective study of 173 adult MDS patients who had not received
disease-altering treatment. Using the Cox hazard method, we found the IPSS-R to be a significant …